HL
BNTX icon

Harding Loevner’s BioNTech BNTX Stock Holding History

Harding Loevner’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,325
Closed -$276K – 68
2024
Q3 		$276K Sell
2,325
-2,924,436
-100% -$269M ﹤0.01% 66
2024
Q2 		$235M Sell
2,926,761
-891,402
-23% -$81.5M 1.3% 27
2024
Q1 		$352M Sell
3,818,163
-126,311
-3% -$12.1M 2.17% 15
2023
Q4 		$411M Buy
+3,944,474
New +$397M 2.31% 12
2022
Q4 		– Sell
-1,202
Closed -$162K – 95
2022
Q3 		$162K Hold
1,202
– – ﹤0.01% 82
2022
Q2 		$179K Buy
+1,202
New +$184K ﹤0.01% 84

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Harding Loevner's BNTX Position: Q4 2024 in Review

Harding Loevner sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 2,325 shares — an estimated $276K sold.

Harding Loevner first reported a position in BNTX in Q2 2022 and held it in 6 quarters. The position peaked at $411M in Q4 2023. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Harding Loevner reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Harding Loevner sold 2,325 BioNTech shares in Q4 2024, an estimated $276K.
  • Harding Loevner first reported a position in BioNTech in Q2 2022 and held it in 6 quarters.
  • Harding Loevner's BioNTech position peaked at $411M in Q4 2023.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Harding Loevner's 13F filing for Q4 2024, filed 14 Feb 2025.